AG真人官方

N2OFF, Inc. (Nasdaq: NITO) has called a 2025 special meeting to seek shareholder approval for four key proposals.

• Acquisition: N2OFF will buy 100% of Israeli oncology start-up MitoCareX Bio Ltd. by issuing new NITO shares equal to 鈮�40% of post-close fully diluted shares plus up to another 25% in milestone stock, $700k cash and up to $1.6 m of future-financing proceeds. MitoCareX founders will also receive 5% RSUs and board control of the subsidiary.
• Reverse split: Board authority to effect a 1-for-2 to 1-for-150 reverse split within 12 months.
• Warrants: Approval to issue 1,850,000 common shares on exercise of a warrant held by L.I.A. Pure Capital Ltd.
• Adjournment: Standard authority if more time is needed to solicit votes.

The board unanimously recommends voting FOR all items. If approved, existing holders face substantial dilution, potential additional issuance through milestones and warrants, and the possibility of a large reverse split to maintain Nasdaq compliance. The deal adds an early-stage oncology platform but exposes N2OFF to R&D funding obligations and integration risks. Two N2OFF directors also serve on MitoCareX seller SciSparc鈥檚 board, creating related-party considerations.

The Form 144 filing relates to a proposed sale of 2,216 MYTE common shares (approx. market value $16,287.60) through Morgan Stanley Smith Barney on or about 07 July 2025. The seller acquired the shares on 30 June 2025 via restricted stock units granted by the issuer, MYT Netherlands Parent B.V. (MYTE). A prior Rule 10b5-1 sale of 10,000 shares on 14 May 2025 for $100,457 is also disclosed. The proposed sale represents roughly 0.0016 % of the company鈥檚 136,374,256 shares outstanding, indicating an immaterial impact on the public float. No additional financial metrics, earnings data, or corporate developments accompany the notice. The signer certifies no undisclosed material adverse information. Overall, this is a routine administrative filing signalling a minor potential insider transaction rather than a strategic corporate event.

ChargePoint Holdings, Inc. (NYSE: CHPT) filed an 8-K covering board and corporate actions taken between 7-7-2025 and 7-9-2025.

Key personnel change: Chief Legal Officer & Corporate Secretary Rebecca Chavez will resign effective July 25, 2025 to pursue another opportunity.

2025 Annual Meeting results (58.6 % quorum):

• Four Class II directors were re-elected to serve until 2028.
• PWC ratified as independent auditor for FY 2026.
• Advisory 鈥渟ay-on-pay鈥� passed (80.3 m for vs. 15.2 m against).
• Reverse Stock Split amendment approved (232.9 m for, 34.1 m against) allowing a split ratio between 1-for-2 and 1-for-30.
• Corporate Opportunity Waiver amendment failed.
• Adjournment authority approved.

Reverse stock split executed: On July 9, 2025 the Nominating & Governance Committee set the ratio at 1-for-20, effective 12:01 a.m. ET on July 28 2025. Outstanding shares will drop from ~467.1 million to ~23.4 million; equity awards, warrants and convertible notes will be proportionally adjusted. No fractional shares will be issued; cash will be paid in lieu. The action targets regaining NYSE compliance after falling below the US$1.00 minimum price in February 2025. Trading symbol remains CHPT; new CUSIP 15961R 303.

Material implications for investors:

• The split should immediately lift the per-share price and preserve the NYSE listing, but it does not improve underlying fundamentals.
• Share count reduction may increase per-share metrics (EPS, book value) mechanically, with no change in proportional ownership.
• Departure of the CLO introduces near-term succession and governance risk.
• Failure of the corporate opportunity waiver suggests some shareholder concern over governance amendments.

On 07/07/2025, Viasat Inc. (VSAT) President, Commercial Services, James Michael Dodd filed a Form 4 reporting routine equity activity. He converted 8,334 restricted stock units (RSUs) into common shares at a $0 exercise price (Code M). To satisfy statutory tax withholding, 3,280 shares were automatically withheld by the company at $15.93 per share (Code F). Net of the withholding, Dodd鈥檚 direct ownership increased by 5,054 shares, bringing his direct stake to 45,963 common shares; he also retains 3,865 shares held indirectly via his 401(k).

Dodd still holds 16,666 unvested RSUs from an original 25,000-unit grant dated 06/07/2024, scheduled to vest in two equal tranches over the next two years, contingent upon continued employment. No open-market transactions or discretionary sales occurred鈥攐nly automatic tax-related share withholding鈥攕o the filing reflects a scheduled vesting event rather than a strategic insider trade. The disclosure does not signal any shift in corporate outlook or governance and is unlikely to materially affect the investment thesis for VSAT.

Sezzle Inc. (SEZL) 鈥� Form 4 insider transaction

Chief Financial Officer Karen Hartje sold an aggregate 5,484 shares of Sezzle common stock on 7 July 2025 under a pre-arranged Rule 10b5-1 trading plan adopted 20 Sep 2024. Sales were executed in five tranches at weighted-average prices ranging from $166.86 to $179.00 per share. Following the transactions, Hartje directly owns 126,846 shares, down roughly 4 % from the prior 132,330 shares.

The filing reports only non-derivative sales; no option exercises or other derivative activity occurred. Because the plan was disclosed and Hartje retains a sizeable equity stake, the move appears to be routine portfolio diversification rather than a strategic shift, but it nevertheless represents modest insider selling pressure.

Viasat Inc. (VSAT) 鈥� Form 4 insider filing

On 07 July 2025, Girish Chandran, President, Global Space Networks, reported the vesting of 8,334 restricted stock units (transaction code 鈥淢鈥�). The RSUs converted 1-for-1 into common shares at no cost. To satisfy payroll-tax obligations, 4,488 shares were automatically surrendered to the company at $15.93 per share (code 鈥淔鈥�), leaving a net increase of 3,846 shares in Chandran鈥檚 direct holdings.

Post-transaction ownership: 46,255 direct shares, 5,644 shares in the officer鈥檚 401(k) and 176 in a spouse 401(k), plus 16,666 unvested RSUs remaining from the original 25,000-unit grant dated 06 Jun 2024. The next two RSU tranches are scheduled to vest on the second and third anniversaries of that grant, subject to continued employment.

No open-market purchase or sale occurred; the filing reflects routine equity-compensation vesting and tax withholding. Therefore, the signal for investors is considered neutral with limited immediate impact on Viasat鈥檚 valuation.

Ryde Group Ltd (NYSE American: RYDE) has filed a Form F-3 shelf registration to give itself maximum flexibility to raise capital over the next three years.

• Primary shelf: up to US$100 million in Class A ordinary shares, debt securities, warrants, rights or units that may be sold directly, or through underwriters, dealers or agents.
• Rule 415 eligibility: the company鈥檚 public float is only US$4.768 million (14.9 million non-affiliate shares at US$0.32 on 7 Jul 2025). Under Instruction I.B.5, Ryde cannot sell more than one-third of that float (鈮圲S$1.6 million) in any 12-month period until its market value exceeds US$75 million.
• Carry-over securities: (i) 5.3 million Class A shares issuable on exercise of warrants sold in the Sept 2024 follow-on offering; (ii) conversion of the prior Form F-1 registration (File No. 333-282076) into the new shelf.
• Resale component: 8.03 million Class A shares held by Octava Fund Ltd may be offered for secondary sale. Ryde will receive no proceeds.

The filing refreshes capital-raising capacity after a series of corporate actions:

• US$12 million IPO (Mar 2024) and US$4.5 million follow-on (Sept 2024).
• Secondary listings on Frankfurt and Stuttgart (Jun 2024) and several new subsidiaries (BVI and Singapore) to support expansion.
• 40 % stake in Atoll Discovery (Jun 2025) paid with 4.85 million Ryde shares.

Business snapshot. Ryde is a Cayman Islands holding company whose operating subsidiaries in Singapore run a 鈥渟uper mobility app鈥� offering car-pooling, ride-hailing (RydeX, RydeXL, RydeLUXE, RydePET, RydeTAXI) and quick-commerce parcel delivery (RydeSEND). Key strengths cited include dual-segment platform, scalable technology and experienced management.

Key risks spelled out in the prospectus:

• Early-stage growth and continuing losses; profitability hinges on reducing driver/consumer incentives.
• Intense competition from Grab, Gojek, ComfortDelGro, Lalamove and others.
• Regulatory overhang (Platform Workers Act 2024, driver classification, data privacy, AML, LTA licensing).
• Micro-cap status (US$0.32 share price), potential NYSE American listing compliance challenges and dilution from warrants, resale shares and future offerings.
• Technology, cybersecurity and brand-reputation risks inherent in ride-hailing and delivery models.

Use of proceeds will be detailed in future prospectus supplements, but typical purposes include working capital, technology investments and potential acquisitions. The company鈥檚 ability to tap the full US$100 million depends on a significant improvement in market capitalization or uplisting.

Overall, the F-3 positions Ryde to raise incremental capital quickly, continue warrant coverage and permit shareholder liquidity, while highlighting substantial competitive, operational and regulatory headwinds that investors must weigh.